MRS332 Nuclear Medicine Science 3 (16)

This subject completes the students' comprehensive education in Nuclear Medicine science and prepares students for the 4th year residency. Students consolidate their developing knowledge and skills including those associated with the important applications such as: diagnostic oncology, therapeutic oncology, Positron Emission Tomography (PET), pre-clinical imaging and non-imaging techniques. Students continue to develop their understanding of the principles and practice of Nuclear Medicine Science underpinned by professional practice in the clinical setting (6 weeks clinical practicum). The theoretical modules of this subject are designed to develop the requisite knowledge, skills and capabilities required for graduate entry professional registration. Students will also further develop critical evaluation and reflective practice skills.

No offerings have been identified for this subject in 2020.

Where differences exist between the Handbook and the SAL, the SAL should be taken as containing the correct subject offering details.

Subject Information

Grading System



One session


School of Dentistry and Health Sciences

Enrolment Restrictions

 Bachelor of Medical Radiation Science (Nuclear Medicine and Molecular Imaging)



Subject Relationships

MRS322 MRS332 is a revision of MRS322 enabling updating of the ASCED code

Incompatible Subjects


Learning Outcomes

Upon successful completion of this subject, students should:
  • be able to describe, explain and implement professional practice with specific reference to applying anatomy, physiology and pathology, applying the principles of physics and instrumentation, utilising patient information management systems, determining appropriate procedures, patient assessment and due diligence, deliver appropriate care, and manage / manipulate 3D datasets (MRPBA Domain 5);
  • be able to apply understanding of practice in Nuclear Medicine, demonstrating critical evaluation and analytical skills, with specific reference to implementing preparation of radiopharmaceuticals, explaining diagnostic and therapeutic radiopharmaceutical biodistribution, implementing routine imaging including SPECT/CT and PET/CT, implement CT imaging, implement nuclear medicine examinations and therapies and describe in vivo and in vitro laboratory procedures (MRPBA Domain 5B);
  • be able to apply the principles of radiation safety and risk management, demonstrating critical evaluation and analytical skills, with specific reference to safe radiation practice, protecting/enhancing patient safety, ensuring safe operation of equipment, maintain safety of self and others and safely managing radiation and radioactivity (MRPBA Domain 4);
  • be able to demonstrate communication and collaboration skills with specific reference to clear, sensitive, effective and culturally appropriate communication creating culturally safe environments and collaborating with other health practitioners (MRPBA Domain 2);
  • be able to identify, explain and implement professional, non-discriminatory and ethical conduct with specific reference to practicing in an ethical, professional and legal manner, providing appropriate care, assuming accountability and responsibility, and patient advocacy (MRPBA Domain 1); and
  • be able to apply the principles of evidence based practice and professional learning with specific reference to critical and reflective thinking to resolve clinical challenges and identifying professional learning needs / life-long learning (MRPBA Domain 3).


This subject will cover the following topics:
  • CLINICAL BLOCK (1 x 6 weeks):
  • Professionalism;
  • Ethics and law;
  • Social and environmental justice;
  • Radiation safety;
  • Patient care and communication;
  • Culturally safe environments
  • WHS;
  • Technical competence; and
  • Reflective practice.
  • Oncology (diagnostic and therapeutic);
  • Positron Emission Tomography (PET);
  • Non imaging; and
  • Pre-clinical.
  • Terminology;
  • Protocol and procedure;
  • Radiopharmacy;
  • Pathophysiology / clinical indications;
  • Quantitative and data analysis;
  • Paediatric considerations;
  • Image interpretation; and
  • Integrative imaging.

Workplace Learning

This subject contains a 30 days Compulsory Workplace Learning component.

Students undertake 1 block of 6 weeks (30 eight hour days). Placement occurs at approved clinical sites as recognised by MRPBA. This includes approved sites in rural, regional and metropolitan sites; and public and private departments. Students undertake the placement at one site for the practicum period.

Special Resources

Students undertake a 6 week clinical placement which require students to undertake travel at their own expense (including travel, accommodation and uniforms).

Students undertake pre-clinical practical activities in CSU laboratories and in clinical centres that partner with CSU.

The information contained in the CSU Handbook was accurate at the date of publication: July 2020. The University reserves the right to vary the information at any time without notice.